Premature Ejaculation
📧 Sign up to get email alerts when something new happens for Premature Ejaculation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-10-03Clinical Trial Update: Phase 2 Trial of PED-1 and PED-2 in Male Patients With Premature Ejaculation [Phase 2]
The Phase 2 trial of PED-1 and PED-2 for premature ejaculation has completed.
-
CLINICAL_TRIALS trial_result · 2012-08-27Clinical Trial Update: Study to Evaluate Efficacy and Safety in Males Subjects With Premature Ejaculation [Phase 3]
A Phase 3 clinical trial evaluating efficacy and safety in male subjects with premature ejaculation has been terminated.
-
CLINICAL_TRIALS trial_result · 2012-08-27Clinical Trial Update: Study to Evaluate Efficacy and Safety in Male Subjects With Premature Ejaculation [Phase 3]
A Phase 3 trial evaluating efficacy and safety in male subjects with premature ejaculation has been terminated.
-
CLINICAL_TRIALS trial_result · 2012-08-01Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Efficacy of YHD1044 [Phase 1, Phase 2]
The document summarizes safety, tolerability, pharmacokinetics and efficacy findings for the investigational drug YHD1044 in Phase 1 and Pha…
-
CLINICAL_TRIALS trial_result · 2012-07-11Clinical Trial Update: A Study to Characterize the Pharmacokinetics of DA-8031 in Healthy Male Subjects [Phase 1]
A completed Phase 1 pharmacokinetics study of DA-8031 in healthy male volunteers to characterize its PK profile for premature ejaculation.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-03-19Clinical Trial Update: A Study On Concentrations Of 16448 In Blood And The Safety Of This Compound In Healthy Males With Premature Ejaculation [Phase 2]
A Phase 2 study evaluating blood concentrations and safety of the compound 16448 in healthy male volunteers with premature ejaculation; the …
-
CLINICAL_TRIALS trial_result · 2012-03-19Clinical Trial Update: A Study To Assess The Pharmacokinetics Of Different Modified Release Formulations Of GSK221149 In Healthy Adult Subjects [Phase 1]
Phase 1 pharmacokinetics study of different modified-release formulations of GSK221149 in healthy adult subjects has been terminated.
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: A Study of Withdrawal Effects With Dapoxetine in the Treatment of Premature Ejaculation [Phase 3]
Phase 3 clinical trial update focusing on withdrawal effects observed with dapoxetine for treating premature ejaculation.
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation [Phase 3]
This clinical trial update reports the results of a Phase 3 study evaluating the effectiveness and safety of dapoxetine for treating prematu…
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation [Phase 3]
Phase 3 clinical trial assessing the effectiveness and safety of dapoxetine for premature ejaculation has been completed.
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation. [Phase 3]
Phase 3 study assessing the effectiveness and safety of dapoxetine for premature ejaculation has completed.
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: An Open-Label Study of the Long-Term Safety of Dapoxetine HCl in the Treatment of Rapid Ejaculation [Phase 3]
An open-label Phase 3 study assessing the long-term safety of dapoxetine hydrochloride for rapid ejaculation has completed. The trial includ…
-
CLINICAL_TRIALS trial_result · 2011-02-11Clinical Trial Update: A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation [Phase 3]
Phase 3 clinical trial assessing the effectiveness and safety of dapoxetine for treating premature ejaculation has completed.
-
CLINICAL_TRIALS trial_result · 2009-12-02Clinical Trial Update: Efficacy and Safety of Paroxetine Daily Doses of 15 mg and 20 mg in the Treatment of Premature Ejaculation [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of daily paroxetine at 15 mg and 20 mg for premature ejaculation has completed.
-
CLINICAL_TRIALS trial_result · 2008-04-11Clinical Trial Update: Safety and Efficacy of Escitalopram in the Treatment of Premature Ejaculation [EARLY_Phase 1]
An early-phase study evaluating the safety and efficacy of escitalopram for premature ejaculation, sponsored by Cairo University; the curren…